Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, according to a new survey that was published on Friday. The new ...

These compounds take a different approach to weight loss than existing medications, which can cause nausea, vomiting and ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...

Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight ...

The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.

The following content is for informational purposes only. This article is not intended to be a substitute for profession ...

Weight loss drugs like Ozempic and Wegovy have dominated the diet discussion for the past few years. But this trend leaves many people wondering: What role does weight-loss surgery play in an ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...